Radiomics-based machine learning in prediction of response to neoadjuvant chemotherapy in osteosarcoma: A systematic review and meta-analysis
Authors:
- 9 May 2025
- journal article
- review article
- Published by Elsevier in Clinical Imaging
- Vol. 123, 110494
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- T2-weighted MRI radiomics in high-grade intramedullary osteosarcoma: predictive accuracy in assessing histologic response to chemotherapy, overall survival, and disease-free survivalSkeletal Radiology, 2022
- MRI-based radiomics signature for pretreatment prediction of pathological response to neoadjuvant chemotherapy in osteosarcoma: a multicenter studyEuropean Radiology, 2021
- Prognostic value of tumoral and peritumoral magnetic resonance parameters in osteosarcoma patients for monitoring chemotherapy responseEuropean Radiology, 2020
- Pre‐Operative chemotherapy response assessed by contrast‐enhanced MRI can predict the prognosis of Enneking surgical margins in patients with osteosarcomaJournal of Orthopaedic Research, 2018
- Review of dynamic contrast‐enhanced MRI: Technical aspects and applications in the musculoskeletal systemJournal of Magnetic Resonance Imaging, 2017
- Location of residual viable tumor cells after neoadjuvant chemotherapy: A new concept with high prognostic performance in osteosarcomaJournal of Surgical Oncology, 2017
- Early response monitoring to neoadjuvant chemotherapy in osteosarcoma using sequential 18 F-FDG PET/CT and MRIEuropean Journal of Nuclear Medicine and Molecular Imaging, 2014
- Osteosarcoma incidence and survival rates from 1973 to 2004Cancer, 2009
- Recent advances in the chemotherapy of metastatic osteogenic sarcomaCancer, 1972
- Therapeutic effect and toxicity of adriamycin in patients with neoplastic diseaseCancer, 1971